|IUPAC Name||3-([2-(diaminomethyleneamino)thiazol- 4-yl]methylthio)- N’-sulfamoylpropanimidamide|
|Application||For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).|
A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. This compound belongs to the 2,4-disubstituted thiazoles. These are compounds containing a thiazole ring substituted at positions 2 and 4 only.
- ganor; mk208; Ifada; gaster; motiax; muclox; pepcid; pepdul; peptan; fibonel